Peroxisome proliferator-activated receptor gamma agonists and the treatment of HIV-associated lipoatrophy: unraveling the molecular mechanism of their shortcomings
J Infect Dis
.
2008 Dec 15;198(12):1729-31.
doi: 10.1086/593180.
Author
Colleen Hadigan
PMID:
18954262
DOI:
10.1086/593180
No abstract available
Publication types
Comment
Editorial
MeSH terms
Anti-HIV Agents / adverse effects*
HIV-Associated Lipodystrophy Syndrome / chemically induced*
HIV-Associated Lipodystrophy Syndrome / drug therapy*
Humans
PPAR gamma / agonists*
Substances
Anti-HIV Agents
PPAR gamma